title: Quantifying home medication regimen changes and quality of life in patients receiving nocturnal home hemodialysis.
abstract: Medication regimen simplification may improve adherence in end-stage kidney disease. The effect of nocturnal home hemodialysis (NHHD) on medication burden is unknown. A retrospective pilot study of NHHD patients was conducted. Medication information was collected at baseline, NHHD start, and at 3, 6, 12, 18, and 24 months. SF-36 scores were collected at baseline, 6, 12, and 24 months. The number of medications, pill burden, and number of administrations per day were determined. Medication Regimen Complexity Index was used at each time point as a comparator. Medications for anemia, mineral and bone disorders (MBD), cardiovascular (CV) disease, infection, and vitamins were analyzed for number of medications and pill burden. Thirty-five patients were included. Patients used 10.5 ± 4.4 medications at baseline and 11.8 ± 4.7 at the end of the study (P=NS). Regarding the number of medications, anemia medications, anti-infectives, and vitamins increased; MBD and CV medications decreased by the end of the study. Total pill burden did not change over 24 months, nor did anemia pill burden. Mineral bone disorder and CV pill burden decreased, and vitamins and anti-infective pill burden increased. Daily medication administration times decreased significantly from 5.0 ± 1.5 to 3.6 ± 1.5 by 24 months. Switching to NHHD was associated with a significant increase in Medication Regimen Complexity Index at 24 months (P<0.05). SF-36 scores increased significantly once patients began on NHHD. No measure of medication regimen complexity was correlated with the SF-36 score. Medication burden changes over time after starting NHHD. It is unknown what effect NHHD has on adherence or medication costs, and warrants further study in a prospective comparative investigation.
authors.affiliation: Department of Pharmacy Practice, Albany College of Pharmacy and Health Sciences, Albany, New York, USA. katie.cardone@acphs.edu
authors.forename: Katie E
authors.initials: KE
authors.lastname: Cardone
authors.forename: Harold J
authors.initials: HJ
authors.lastname: Manley
authors.forename: Darren W
authors.initials: DW
authors.lastname: Grabe
authors.forename: Shari
authors.initials: S
authors.lastname: Meola
authors.forename: Christopher D
authors.initials: CD
authors.lastname: Hoy
authors.forename: George R
authors.initials: GR
authors.lastname: Bailie
mesh_terms: D004334:Drug Administration Schedule; D005260:Female; D006437:Hemodialysis, Home / Q000379:methods* / Q000592:standards*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000188:drug therapy / Q000628:therapy*; D008297:Male; D055118:Medication Adherence; D008875:Middle Aged; D017410:Practice Guidelines as Topic; D011788:Quality of Life; D012189:Retrospective Studies; D013997:Time Factors